Main menu

Genetic Variation, Comparative Genomics, and the Diagnosis of Disease


The discovery of mutations associated with human genetic disease is an exercise in comparative genomics (see Glossary). Although thereare many different strategies and approaches, the central premise is that affected persons harbor a significant excess of pathogenic DNA variants as compared with a group of unaffected persons (controls) that is either clinically defined or established by surveying large swaths of the general population.The more exclusive the variant is to the disease, the greater its penetrance, the larger its effect size,and the more relevant it becomes to both disease diagnosis and future therapeutic investigation.

The most popular approach used by researchers in human geneticsis the case–control design, but there are others that can be used to track variants and disease in a family context or that consider the probability of different classesof mutations based on evolutionary patterns of divergence or de novo mutational change. Although the approaches may be straightforward, the discovery of pathogenic variation and its mechanism of action often is less trivial, and decades of research can be required in order to identify the variants underlying both mendelian and complex genetic traits.

Authors: Evan E. Eichler, Ph.D

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag